Skip to content

A post market clinical follow-up study with the aneXys acetabular cup and ceramys inlay

A post market clinical follow-up study with the aneXys acetabular cup and ceramys inlay

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00021508
Enrollment
150
Registered
2020-04-24
Start date
2021-03-15
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M16.1 M16.7

Interventions

Group 1: single-arm study (no comparison group) Patients who have been treatet with an aneXys hip cup and a ceramys inlay are re-examined 4 times after surgery using the following scores: -MONA Que

Sponsors

Mathys AG Bettlach
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: - Informed consent form (signed by participant and investigator) - Primary implantation - Suffer from primary or secondary osteoarthritis of the hip, femoral head and neck fractures or necrosis of the femoral head. In all cases a stable anchoring of the implant has to be possible - Age at inclusion: between 18 and 75 years old - Willing to participate in the follow-up examinations mentioned above - Complete recovery is expected

Exclusion criteria

Exclusion criteria: - Missing informed consent form (signed by participant and investigator) - Known or suspected non-compliance (e.g. drug or alcohol abuse) - Enrolment of the investigator, his/her family, employees and other dependent persons - Patients younger 18 years old - Revision surgery - Presence of sepsis or malignant tumours - ASA (American Society of Anesthesiologists) Classification >3 - Pregnancy - Patients not able to speak and understand the national language of the study center

Design outcomes

Primary

MeasureTime frame
The primary endpoint is defined as assessment of acoustic emission based on the MONA Questionnaire. For assessment of the primary endpoint, the MONA Questionnaire is assessed at 24 months (range: 24-26 months) postoperative.

Secondary

MeasureTime frame
The secondary endpoint will be the determination of the clinical outcome using the HHS (Harris Hip Score), UCLA (University of California) Activity Score, EQ-5D-5L Score, FJS (Forgotten-Joint-Score) and VAS pain and satisfaction.

Countries

Germany

Contacts

Public ContactChiara Lenarduzzi

Mathys AG Bettlach

SurgicalCompanyInitiatedStudiesOUS@enovis.com+39 0432 945511

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026